:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Megan H. Check, Sarah E. Ernst, Karen S. Sfanos
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	The Prostate
Online Access:	https://onlinelibrary.wiley.com/doi/10.1002/pros.70013
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of Cell‐Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2‐ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance
by: Marco Oderda, et al.
Published: (2025)

ERG and PTEN Role on Active Surveillance for Low‐Risk Prostate Cancer in the Multiparametric MRI Era
by: Marco Aurelio Watanabe Yorioka, et al.
Published: (2024)

Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo‐Controlled, Biomarker‐Enriched Trial in Patients With the SOD2 Ala/Ala Variant
by: A. Mandl, et al.
Published: (2025)

Impact of Genomic Mutations on the Transcriptional Pathways and Tumor Microenvironment Landscape of Localized Early Prostate Cancer
by: William Lautert‐Dutra, et al.
Published: (2026)

pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy
by: Piotr Bialas, et al.
Published: (2024)

Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes
by: Christian P. Pavlovich, et al.
Published: (2025)

Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy
by: Yuto Ono, et al.
Published: (2025)

A Gene Expression Tumor Signature Optimizing Partial Area‐Under‐the‐Curve (pAUC) to Improve Specificity for Indolent Prostate Cancer
by: Travis A. Gerke, et al.
Published: (2026)

Developments in Ultrasound‐Based Imaging for Prostate Cancer Detection
by: Reid Vassallo, et al.
Published: (2025)

Reply – Letter to the Editor: Bimodal Imaging at MRI Fusion Prostate Biopsy Will Gain Further Importance in the Future
by: Fabian Falkenbach, et al.
Published: (2025)

Automatic MRI‐TRUS Fusion Technique for Transperineal Biopsy Guidance: From Preoperative Planning to Intraoperative Navigation
by: Lu Tang, et al.
Published: (2024)

Consistent predictive ability of prostate‐specific antigen density prediction model for clinically significant prostate cancer across age strata
by: Kamil Malshy, et al.
Published: (2024)

Corticosteroid Use and Risk of Adverse Events in Metastatic Hormone‐Sensitive Prostate Cancer
by: Umang Swami, et al.
Published: (2026)

Racial Disparities in the Use of MRI and PET Scan Among Medicare Beneficiaries With Prostate Cancer
by: Hanna Zurl, et al.
Published: (2025)

In Vitro Effects of Cabazitaxel and Menadione on Cell Growth, Metabolism, and Transcriptomic Profile of Human Prostate Cancer Cell Lines
by: Ana Laura Gómez-Rosas, et al.
Published: (2026)

Is Saturation Biopsy Still a Viable Alternative to Fusion Biopsy in the Era of Multiparametric MRI? A Comparative Analysis in Patients With Prior Negative Biopsy
by: Arda Taşkın Taşkıran, et al.
Published: (2026)

Downregulation of NONO Suppresses Proliferation, Migration, and Invasion in Metastatic Prostate Cancer
by: Anna‐Lena Lemster, et al.
Published: (2025)

Clinical validation of circulating GDF15/MIC‐1 as a marker of response to docetaxel and survival in men with metastatic castration‐resistant prostate cancer
by: Kate L. Mahon, et al.
Published: (2024)

The Role of Secondary Lesion Biopsy in Detecting Clinically Significant Prostate Cancer
by: Trevor C. Hunt, et al.
Published: (2025)

Socioeconomic and Demographic Factors in Genetic Testing Utilization Among Advanced Prostate Cancer Patients
by: Alexandra T. Skowron, et al.
Published: (2026)

Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible to transrectal ultrasound
by: Fabian Falkenbach, et al.
Published: (2024)

Utility of the PROSTest, a Novel Blood‐Based Molecular Assay, Versus PSA for Prostate Cancer Stratification and Detection of Disease
by: Mark Kidd, et al.
Published: (2025)

Cancer cells employ lipid droplets to survive toxic stress
by: Laurie G. Kostecka, et al.
Published: (2024)

Influence of 5‐Alpha Reductase Inhibitors on PI‐RADS Scores and Prostate Cancer Detection: A Systematic Review and Meta‐Analysis
by: Lian Qiong, et al.
Published: (2025)

Co‐targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis
by: LaKendria K. Brown, et al.
Published: (2024)

Beyond Baseline: Serial PSA Measurements and Risk Stratification for Prostate Cancer
by: Anwar E. Ahmed, et al.
Published: (2025)

Comparative Evaluation of Detection Rates for Clinically Significant Prostate Cancer Using MRI‐Targeted Biopsy Alone Versus in Combination With Systematic Biopsies: Development of a Risk‐Stratification Scoring System
by: Toshifumi Takahashi, et al.
Published: (2024)

Human Epidermal Growth Factor Receptor 2 Expression in Prostatic Carcinomas: A Systematic Review and Meta‐Analysis of a Potential Therapeutic Target
by: Jacky T. F. Luk, et al.
Published: (2026)

Distribution of neurovascular structures within the prostate gland and their relationship to complications after radical prostatectomy
by: Ghazi Alanazi, et al.
Published: (2024)

Deep PSA response and extended time‐to‐nadir as robust predictors of survival in Asian patients with de novo metastatic hormone‐sensitive prostate cancer receiving upfront intensified treatment
by: Chris H.‐M. Wong, et al.
Published: (2024)

Effects of Concurrent Administration of Spironolactone in Veterans with Metastatic Prostate Cancer Receiving Abiraterone: A Real‐World Retrospective Study
by: Erum Z. Whyne, et al.
Published: (2024)

Modern predictors and management of incidental prostate cancer at holmium enucleation of prostate
by: Eric V. Li, et al.
Published: (2024)

Incidental Brain Metastases From Prostate Cancer Diagnosed With PSMA PET/CT and MRI: A Case Series and Literature Review
by: Mark Willy L. Mondia, et al.
Published: (2025)

RETRACTION: Glyoxalase 2 Is Involved in Human Prostate Cancer Progression as Part of a Mechanism Driven By PTEN/PI3K/AKT/mTOR Signaling With Involvement of PKM2 and ERα
Published: (2024)

Erratum to “Inhibition of Signaling Downstream of Beta‐2 Adrenoceptor by Propranolol in Prostate Cancer Cells”
Published: (2025)

An orthotopic prostate cancer model for new treatment development using syngeneic or patient‐derived tumors
by: Naz Chaudary, et al.
Published: (2024)

A west African ancestry‐associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening
by: Jian Gu, et al.
Published: (2024)

Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS)
by: Dana Cavanaugh, et al.
Published: (2024)

Individualized Precision Prostate Biopsy Strategy for Patients With PI‐RADS Score 2: A Retrospective Multicenter Study
by: Zhiyao Xu, et al.
Published: (2025)

Factors Associated With Male Breast Cancer Incidence Among Prostate Cancer Survivors: Real World Evidence From Veterans Affairs National Prostate Cancer Data Core
by: Erum Z. Whyne, et al.
Published: (2025)